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Disseminated microsporidiosis in a
renal transplant recipient

Abstract: Disseminated microsporidiosis is diagnosed uncommonly in patients
not infected with human immunodeficiency virus (HIV). We present a case of
disseminated microsporidiosis in a renal transplant recipient who was seronegative
for HIV. Chromotrope-based stains were positive for microsporidia in urine, stools,
sputum, and conjunctival scrapings. Electron microscopy, immunofluorescence,
polymerase chain reaction, and cultures of renal tissue identified the organism as
Encephalitozoon cuniculi. The patient was treated with oral albendazole and topical
fumagillin with clinical improvement. In addition, she underwent a transplant
nephrectomy and immunosuppressive therapy was withdrawn. Follow-up samples
were negative for microsporidia. However, the patient developed central nervous
system manifestations and died. An autopsy brain tissue specimen demonstrated
E. cuniculi by immunofluorescent staining. Disseminated microsporidiosis must be
considered in the differential diagnosis of multiorgan involvement in renal allograft
recipients.
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The phylum microsporidia encompasses over 100 genera and 1000
species of protozoa, which are obligate intracellular, spore-forming
organisms. Recently, microsporidia have gained an increasingly
prominent role as opportunistic pathogens in the immunocompromised
host. Enteric infections are common in patients infected with the human
immunodeficiency virus (HIV), but they have also been reported in
immunocompetent and immunocompromised hosts (1±3). Disseminated
disease has also been appreciated in the HIV-positive patient (4±8), but it
is extremely uncommon in the non-HIV-infected host (9). We present a
case of disseminated microsporidiosis with Encephalitozoon cuniculi in an
HIV-seronegative individual with end-stage renal disease following
successful receipt of a renal allograft.
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A treatment regimen consisting of albendazole, 400 mg by mouth twice

Case report

daily, plus fumagillin eye drops was initiated and resulted in clinical
improvement. In addition, the patient underwent an uncomplicated trans-

A 45-year-old-female underwent a living-related donor kidney transplant

plant allograft nephrectomy and all immunosuppressive medications

in the Philippines before returning to her home in Canada. Her post-

were withdrawn. Impression smears of the nephrectomy specimen

transplant course was complicated by two episodes of rejection that

stained with the Gram-chromotrope stain (11) exhibited dark violaceous

were treated with high-dose intravenous methylprednisolone and

spores that varied in size from 1.8 to 2.6 mm. In addition, a large number of

monoclonal anti-CD3 antibodies (muromonab-CD3). Eight weeks fol-

spores demonstrated posterior vacuolation and a midline stripe, charac-

lowing engraftment, the patient developed an intermittent fever. A

teristic of a microsporidial species. An indirect immunofluorescent study

polymerase chain reaction (PCR)-based assay on blood for cytomegalo-

(12) of kidney impression smears demonstrated positive reactivity with

virus (CMV) was positive. She was treated for 2 weeks with intravenous

anti-E. cuniculi serum at a dilution of 1:800 (Fig. 2). Analyses by PCR,

ganciclovir; however, sustained defervescence did not occur. She was

culture, and electron microscopy of the renal tissue were performed as

subsequently admitted for further evaluation and found to have bilateral

previously described (7, 11±15). The PCR analysis demonstrated the

keratoconjunctivitis, allograft tenderness, and an infiltrate on the chest

presence of four GTTT repeats in the internal transcriber spacer, which

radiograph.

is characteristic of genotype III of E. cuniculi (15). Cell cultures, inoculated

Laboratory

studies

revealed

the

following:

leukocyte

count

by renal specimens, revealed foci of infected cells after 2 weeks of

6900 per mm3 (89% polymorphonuclear cells); hemoglobin 8.6 g/dL;

incubation. Smears of culture-derived spores stained dark violet on

platelets 169,000 per mm3; blood urea nitrogen level 57 mg/dL; and

Gram-chromotrope staining and reacted positively with E. cuniculi

serum creatinine level 2.9 mg/dL. Cultures of blood revealed neither growth

antiserum at a titer of . 4096. When reacted with the calcofluor white

of bacteria nor fungi. A PCR-based assay on blood for CMV was negative.

reagent, the spores revealed the characteristic bluish white fluorescence

Histologic sections of percutaneous renal biopsy tissue revealed intact

(Fig. 3). Transmission electron microscopy revealed the presence of an

normal-appearing glomeruli, a moderate tubulointerstitial infiltrate, and

unseptated parasitophorous vacuole (PV) with parasites at different

coccoid-appearing organisms within the cytoplasm of renal tubules.

stages of development and mature smooth-walled spores (Fig. 4).

Chromotrope stains of specimens obtained from urine, stool, sputum,

Meronts were consistently found attached to the PV membrane. The

and conjunctival scrapings were performed as described previously (10).

spores demonstrated approximately five polar tube coils, a thin electron

All of these specimens were positive for microsporidia (Fig. 1).

dense exospore, a thick electron-lucent endospore, and a thin cell

Fig. 1. Microsporidial spores from urinary sediment stained with the chromotrope technique. Magnification, 3 400.
Transplant Infectious Disease 2002: 4: 102±107
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2 µm

Fig. 2. Impression smear of the nephrectomy specimen using immunofluorescence staining. Spore walls and extruded polar tubes
are evident.

5 µm
2 µm

Fig. 3. Smear of the culture supernatant stained with calcofluor white reagent.

membrane surrounding the spore contents. All these features were

developed thrombocytopenia and albendazole and fumagillin were

consistent with the morphological identification of an Encephalitozoon

discontinued after 4 weeks of therapy. During post-transplant week 24,

species.

the patient experienced a generalized seizure that led to a brain magnetic

Treatment resulted in clinical improvement and subsequent evaluation

resonance imaging (MRI) revealing multiple, high-signal areas on T2 and

of the urine, stool, sputum, and conjunctival scrapings using the chromo-

diffusion images, with no significant mass effect. The post-gadolinium

trope stain proved negative for microsporidia. Unfortunately, the patient

study demonstrated diffuse leptomeningeal enhancement. A brain biopsy

104
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Fig. 4. Ultrastructure of Encephalitozoon cuniculi within an E6 monkey kidney cell demonstrating the parasitophorous vacuole
(PV) containing meronts (M) and sporont (ST). Sporont (ST1) is undergoing cytokinesis. Note that the E6 cell mitochondria (mi) are
closely associated with the parasite stages. Inset, a fully developed spore demonstrating the polar tube coils is shown.
was attempted, but the procedure was aborted because of intraoperative

In our patient, microsporidial dissemination was evident from

hemorrhage. The patient expired 26 weeks after transplantation and an

samples of sputum, urine, stools, conjunctivae, brain, and kidney.

autopsy brain tissue specimen demonstrated E. cuniculi by immunofluor-

Confirmatory studies using a variety of techniques identified the

escent staining.

organism as E. cuniculi. In contrast to E. bieneusi, which usually induces
infection limited to the gut and biliary tree, E. cuniculi frequently
causes disseminated disease in HIV-infected individuals. Despite the

Discussion

presence of microsporidia in stool, our patient did not manifest
diarrhea or other gastrointestinal manifestations. Notably, she incurred
a prominent keratoconjunctivitis, a feature well appreciated as a

Intestinal microsporidiosis is a common infection of HIV-infected indivi-

presenting manifestation of disseminated Encephalitozoon infection (9).

duals and the vast majority of cases are caused by Enterocytozoon

Factors that may have contributed to dissemination in our patient likely

bieneusi. Multiorgan involvement with microsporidial species has also

included the employment of high-dose glucocorticoid steroids and

been reported. Sites affected have included the upper and lower

anti-CD3 antibodies during anti-rejection therapy. CMV infection

respiratory tracts, the eye and its adnexae, genitourinary tract, hepato-

may have further enhanced her susceptibility to the microsporidial

biliary tract, musculoskeletal system, and the central nervous system

infection.

(4±9). However, disseminated microsporidiosis has rarely been reported
in patients who are not HIV-infected (9).
Among transplant recipients, only six cases of microsporidial infection

The optimal therapy of microsporidiosis has not been clearly established. However, the benzimidazole derivative, albendazole, has been the
most frequently utilized agent. Albendazole has demonstrated activity

have been reported in detail (16±21). Five patients were solid organ

against microsporidia in vitro and is at least partially effective in

recipients who developed a chronic diarrheal illness (16±20) and a sixth

HIV-infected patients afflicted by chronic sinusitis, lower respiratory

case occurred in an individual who received an allogeneic bone marrow

infections, cerebral infections, urinary tract infections, myositis, and

transplant with an infection limited to the lungs (21). None of these cases

disseminated disease (5, 7, 9). Most of these patients have been infected

demonstrated multiorgan involvement. E. cuniculi has been identified in

by an Encephalitozoon species, particularly E. cuniculi, E. hellem, or

the kidney of an HIV-negative kidney-pancreas transplant recipient;

E. intestinalis. A double-blind, placebo-controlled study of intestinal and

however, no other clinical findings indicating systemic disease were

extraintestinal infection attributable to E. intestinalis in eight HIV-

reported (22).

infected subjects, demonstrated clinical benefit and clearance of the
Transplant Infectious Disease 2002: 4: 102±107
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parasite from stools of all patients treated with albendazole (23). However,

from urine, stool, sputum, and conjunctival scrapings was documented.

the shedding of microsporidial spores in urine continued in five of the

Unfortunately, therapy was terminated due to the development of throm-

eight treated subjects. The therapy of E. bieneusi infestation by any agent

bocytopenia, a side effect common to both drugs. Despite the initial

has been less salutary. Although some AIDS patients with intestinal

positive response to therapy, cerebral disease was proven at autopsy,

microsporidiosis have shown symptomatic improvement with alben-

with brain tissue harboring spores of E. cuniculi.

dazole, intestinal parasitosis persisted in all patients despite treatment

In conclusion, disseminated microsporidiosis, although rare, must be

(24). Other drugs associated with clinical improvement in small number of

considered in the differential diagnosis of multiorgan infection in renal

patients with diarrhea caused by E. bieneusi include thalidomide, furazo-

allograft recipients. Employing a systematic approach toward the

lidone, and oral fumagillin (9).

diagnosis of microsporidia in non-HIV-infected patients, will, as we

Our patient was treated with albendazole, 400 mg twice a day for

anticipate, increase the recognition of additional cases of this morbid

4 weeks, plus fumagillin eye drops for keratoconjunctivitis. In addition,

and lethal illness. In addition, the presence of microsporidia may also

immunosuppression was abbreviated and eradication of microsporidium

reflect susceptibility to other intestinal parasites.
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